Target
Egl nine homolog 1 [181-417]
Ligand
BDBM475405
Substrate
n/a
Meas. Tech.
Enzyme Activity Assay
IC50
79.4±n/a nM
Citation
 Hocutt, FMLeonard, Jr., BEPeltier, HMPhuong, VKRabinowitz, MHRosen, MDTarantino, KTVenkatesan, HZhao, LX Benzoimidazoles as prolyl hydroxylase inhibitors US Patent  US10851083 Publication Date 12/1/2020 
Target
Name:
Egl nine homolog 1 [181-417]
Synonyms:
C1orf12 | EGLN1 | EGLN1_HUMAN | Egl nine homolog 1 (aa 181-417)
Type:
Enzyme
Mol. Mass.:
26555.51
Organism:
Homo sapiens (Human)
Description:
aa 181-417
Residue:
237
Sequence:
PNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKP
  
Inhibitor
Name:
BDBM475405
Synonyms:
1-[5-(3-Trifluoromethyl-phenyl)-1H-benzoimidazol-2-yl]- | US10851083, Example 17 | US11618744, Example 17
Type:
Small organic molecule
Emp. Form.:
C18H11F3N4O2
Mol. Mass.:
372.3007
SMILES:
OC(=O)c1cnn(c1)-c1nc2cc(ccc2[nH]1)-c1cccc(c1)C(F)(F)F
Structure:
Search PDB for entries with ligand similarity: